MolPharm

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by OTTEN, U.
Right arrow Articles by THOENEN, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by OTTEN, U.
Right arrow Articles by THOENEN, H.

Molecular Pharmacology, Vol 12, 353-361, Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics

Selective Induction of Tyrosine Hydroxylase and Dopamine beta-Hydroxylase in Sympathetic Ganglia in Organ Culture: Role of Glucocorticoids as Modulators

U. OTTEN 1 and H. THOENEN 1

1 Department of Pharmacology, Biocenter of the University, Basel, Switzerland

In organ cultures of rat sympathetic ganglia dexamethasone enhanced the synthesis of tyrosine hydroxylase and dopamine beta-hydroxylase in a strictly dose-dependent manner. The maximal effect (tyrosine hydroxylase, +64%; dopamine beta-hydroxylase, +47%) was achieved at 0.1 µM, and at 100 µM control levels were approached again. In contrast, the smaller effect on dopa decarboxylase (+24%) was virtually the same over the concentration range from 10 nM to 1 mM. For all the enzymes studied a 4-hr exposure of the ganglia to glucocorticoids was sufficient to produce a maximal effect after 48 hr. The glucocorticoid-mediated induction of tyrosine hydroxylase and dopamine beta-hydroxylase was dependent on the presence of intact preganglionic cholinergic nerves. In decentralized ganglia the increase in tyrosine hydroxylase was reduced to +22%, and that of dopamine beta-hydroxylase, to +4%. The increase in dopa decarboxylase remained unchanged. The addition of the ganglionic blocking agent chlorisondamine (10 µM) had the same effect as decentralization. In organ cultures originating from adrenalectomized animals carbamylcholine (100 µM) still produced a marked increase in tyrosine hydroxylase and dopamine beta-hydroxylase. It is concluded that glucocorticoids exert a dual effect on sympathetic ganglia: (a) a strictly concentration-dependent induction of tyrosine hydroxylase and dopamine beta-hydroxylase, which depends on the presence of intact preganglionic cholinergic nerves, and (b) a nonspecific general effect on protein synthesis, which is not dependent on intact preganglionic nerves and which is reflected by a small increase of all enzymes studied. Since specific induction of tyrosine hydroxylase and dopamine beta-hydroxylase by carbamylcholine is still possible in ganglia from adrenalectomized animals, the synthesis of these two enzymes seems to be regulated primarily by the activity of the preganglionic nerves, with glucocorticoids playing a modulatory role.

Note:
ACKNOWLEDGMENTS The authors wish to thank Mrs. N. Scott-Lindsay for her excellent technical assistance, and Miss V. Forster for her help in preparation of the manuscript.

Submitted on October 14, 1975




This article has been cited by other articles:


Home page
Cold Spring Harb Symp Quant BiolHome page
K. O'Malley, A. Mauron, G. Makk, D.L. Wong, R.D. Ciaranello, J.D. Barchas, and L. Kedes
Dopamine {beta}-Hydroxylase Rat mRNA: Structure, Regulation, and Tissue Localization
Cold Spring Harb Symp Quant Biol, January 1, 1983; 48(0): 319 - 325.
[Abstract] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1976 by the American Society for Pharmacology and Experimental Therapeutics